Respiratory follow-up after hospitalization for COVID-19: who and when?
Fiche publication
Date publication
mai 2021
Journal
European journal of clinical investigation
Auteurs
Membres identifiés du Cancéropôle Est :
Pr OHANA Mickaël, Pr GENY Bernard
Tous les auteurs :
Riou M, Marcot C, Oulehri W, Enache I, Pistea C, Chatron E, Labani A, Geny B, Ohana M, De Blay F, Kessler R, Charloux A
Lien Pubmed
Résumé
Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress syndrome (ARDS) [1]. Pulmonary function tests (PFT) performed at discharge from hospital showed that >80% of severe COVID-19 patients had lung function impairment [2].
Mots clés
COVID-19, respiratory function, respiratory outcome, respiratory sequelae
Référence
Eur J Clin Invest. 2021 May 17;:e13603